Long term omeprazole use
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Omeprazole Use: Efficacy, Safety, and Risks
Efficacy of Long-Term Omeprazole Use in Reflux Esophagitis
Superior Control of Reflux Esophagitis
Long-term use of omeprazole has been shown to be highly effective in managing refractory reflux esophagitis. Studies indicate that maintenance treatment with omeprazole, whether at 20 mg or 10 mg daily, is significantly more effective than ranitidine in keeping patients in remission over a 12-month period . Additionally, patients with severe reflux esophagitis who were resistant to H2-receptor antagonists experienced a low relapse rate of esophagitis during long-term omeprazole therapy, with all relapses being successfully managed by adjusting the omeprazole dose .
Comparison with Antireflux Surgery
In a 12-year comparative study, both omeprazole and antireflux surgery were found to be effective long-term treatments for gastroesophageal reflux disease (GERD). However, surgery was slightly more effective in maintaining continuous remission. Despite this, a significant number of surgical patients required additional medical therapy or another operation, whereas omeprazole patients had fewer changes in therapeutic strategy .
Safety Profile of Long-Term Omeprazole Use
General Safety and Tolerability
Long-term omeprazole therapy has been generally well-tolerated, with an adverse event profile similar to that of short-term treatment and comparable to H2-receptor antagonists like ranitidine and cimetidine . No serious adverse events directly related to omeprazole were reported, and the rate of adverse events decreased over time .
Gastric Mucosal Changes
Long-term omeprazole use has been associated with some changes in the gastric mucosa. In patients with severe reflux esophagitis, the annual incidence of gastric corpus mucosal atrophy was higher in Helicobacter pylori-positive patients compared to H. pylori-negative patients. However, no dysplasia or neoplasms were observed, and corpus intestinal metaplasia was rare .
Impact on Gastrin Levels and Acid Output
Patients on long-term omeprazole therapy showed elevated serum gastrin levels, which normalized quickly upon cessation of the drug. Gastric acid production also returned to baseline levels within 10 days of stopping omeprazole, leading to a rapid recurrence of reflux symptoms and esophagitis .
Risks Associated with Long-Term Omeprazole Use
Genomic Instability and Cancer Risk
There is evidence suggesting that long-term omeprazole use may induce genomic instability, potentially increasing the risk of gastric cancer. Adverse effects reported include atrophic gastritis, cobalamin deficiencies, and polyp development. These findings highlight the need for caution in long-term therapeutic strategies and self-medication practices .
Zollinger-Ellison Syndrome Management
In patients with Zollinger-Ellison syndrome, long-term omeprazole therapy has been effective in controlling gastric acid secretion and preventing mucosal disease. However, the required doses of omeprazole were often high, and some patients needed dose adjustments over time. Despite these high doses, no significant side effects or evidence of gastric carcinoid formation were observed 35.
Conclusion
Long-term omeprazole therapy is effective and generally safe for managing conditions like refractory reflux esophagitis and Zollinger-Ellison syndrome. However, it is associated with some risks, including potential gastric mucosal changes and an increased risk of gastric cancer. Regular monitoring and appropriate dose adjustments are essential to mitigate these risks.
Sources and full results
Most relevant research papers on this topic
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
Long-term omeprazole therapy (up to 11 years) is highly effective and safe for controlling reflux esophagitis in patients not eligible for surgery.
Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Omeprazole (20 or 10 mg once daily) is superior to ranitidine (150 mg twice daily) in maintaining remission in patients with erosive reflux esophagitis over a 12-month period.
Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
Omeprazole is a safe and effective long-term treatment for Zollinger-Ellison syndrome, with no evidence of hematologic, biochemical, or gastric toxicity.
Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer
Long-term use of omeprazole may induce genomic instability and increase the risk of certain types of cancer, requiring adequate precautions.
Use of omeprazole in Zollinger‐Ellison syndrome: a prospective nine‐year study of efficacy and safety
Omeprazole effectively and safely controls gastric acid hypersecretion in all patients with Zollinger-Ellison syndrome for up to nine years without evidence of tachyphylaxis.
Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety
Omeprazole is an effective and safe long-term treatment for refractory reflux esophagitis, with no significant recurrence after discontinuing therapy.
Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.
Antireflux surgery is superior to omeprazole in controlling overall GERD symptoms, but post-fundoplication complaints continue after surgery.
DOI